Jin Yang Pharmaceutical Co., Ltd. announces an Equity Buyback for 158,983 shares.
August 24, 2022 at 04:34 am EDT
Share
Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:A007370) announces a share repurchase program. Under the program, the company will repurchase up to 158,983 shares, pursuant to a trust contract with Samsung Securities. The purpose of the program is to stabilize stock price and uplift the value of shareholders.
The program will expire on November 24, 2022. As of August 23, 2022, the company had 1,065,480 shares in treasury within scope available for dividend and had 0 shares in treasury under other acquisitions.
JIN YANG PHARMACEUTICAL CO., LTD is a Korea-based company mainly engaged in the manufacturing and distributing of medicine and medicine supplies. The Companyâs products consist of drugs for the circulation systems, digestive organs and the central nervous systems, antibiotics, metabolic drugs, and others including antihistaminic agents, anti-inflammatory analgesic drugs, antimicrobials, muscle relaxants, psychotropic agents, high blood pressure medicines, diabetes medicines, injection medicines, skin disease medicines, nutritional supplements, anemia medicines, dental care drugs, ophthalmology care drugs and others. The Company distributes its products within domestic market and to overseas markets.
JIN YANG PHARMACEUTICAL CO., LTD. 
